These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2332609)

  • 1. Pharmacokinetics of lithium in patients treated with controlled release lithium formulations.
    Phillips JD; Myers DH; King JR; Armond AD; Derham C; Puranik A; Corbett JA; Birch NJ
    Int Clin Psychopharmacol; 1990 Jan; 5(1):65-9. PubMed ID: 2332609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ups and downs of oral lithium dosing.
    Kilts CD
    J Clin Psychiatry; 1998; 59 Suppl 6():21-6; discussion 27. PubMed ID: 9674933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of a single-point dosing protocol for predicting steady-state lithium levels.
    Perry PJ; Alexander B; Prince RA; Dunner FJ
    Br J Psychiatry; 1986 Apr; 148():401-5. PubMed ID: 3089352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of lithium pharmacokinetics in patients with affective illness.
    Lehmann W; Kanarkowski R; Matkowski K; Rybakowski J
    Pol J Pharmacol Pharm; 1988; 40(1):47-54. PubMed ID: 3237558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum drug level monitoring in affective disorders.
    Krska J; Corner DA
    J Clin Pharm Ther; 1992 Dec; 17(6):357-63. PubMed ID: 1287028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lithium levels and therapeutic outcome in the prophylaxis of affective disorders: a retrospective study.
    Sashidharan SP; McGuire RJ; Glen AI
    Br J Psychiatry; 1982 Jun; 140():619-22. PubMed ID: 7104552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age on lithium therapy.
    Slater V; Milanes F; Talcott V; Okafor KC
    South Med J; 1984 Feb; 77(2):153-4, 158. PubMed ID: 6701582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of standard and slow-release oral lithium carbonate products.
    Wallis J; Miller R; McFadyen ML; Carlile JB
    S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
    Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
    J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects.
    Shelley RK; Silverstone T
    Int Clin Psychopharmacol; 1986 Oct; 1(4):324-31. PubMed ID: 3104448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of two lithium maintenance dose schedules.
    Perry PJ; Alexander B; Prince RA; Dunner FJ
    J Clin Psychopharmacol; 1984 Oct; 4(5):242-6. PubMed ID: 6490961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of lithium maintenance doses using a single point prediction protocol.
    Perry PJ; Prince RA; Alexander B; Dunner FJ
    J Clin Psychopharmacol; 1983 Feb; 3(1):13-7. PubMed ID: 6833518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of lithium preparations in patients.
    Johnson GF; Hunt GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of lithium from lithium citrate syrup versus conventional lithium carbonate tablets.
    Guelen PJ; Janssen TJ; De Witte TC; Vree TB; Benson K
    Biopharm Drug Dispos; 1992 Oct; 13(7):503-11. PubMed ID: 1489941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical study on the pharmacokinetics of lithium carbonate.
    Ku JS; Wu ZY; Fang YS; Pei YY
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):648-50. PubMed ID: 3125117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of the erythro-plasmatic ratio of lithium (author's transl)].
    Braccini T; Darcourt G; Corti H; Lapalus P; Lavagna J; Myquel M
    Acta Psychiatr Belg; 1980; 80(4):413-9. PubMed ID: 6116378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prediction of therapeutic dosage of lithium].
    Zhang MY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):239-41. PubMed ID: 6536458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.